NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-046-1994-0-GB-08 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS GB EP 95908666.1 Abandoned
NCI E-046-1994-0-FR-07 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS FR EP 95908666.1 Abandoned
NCI E-046-1994-0-DE-05 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS DE EP 95908666.1 Abandoned
NCI E-046-1994-0-EP-06 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS EP National Stage 95908666.1 Abandoned
NCI E-046-1994-0-AU-03 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS AU National Stage 16902/95 Abandoned
NCI E-046-1994-0-PCT-02 Fusion Proteins that Include Antibody and Nonantibody Portions PCT PCT PCT/US1995/000974 Expired
NCI E-046-1994-0-CA-04 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS CA National Stage 2182498 Abandoned
NCI E-046-1994-0-JP-09 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS JP National Stage 7-520642 Abandoned
NIDA E-172-1993-0-PCT-02 No_Patent_Title PCT PCT PCT/US95/01144 Abandoned
NIMH E-151-1995-0-US-01 PORTABLE LIGHT DOSAGE SYSTEM US FWC 08/380,459 Expired
NICHD E-133-1990-0-US-02 GOSSYPOL FOR THE TREATMENT OF CANCER US DIV 08/379,872 6114397 Abandoned PDF
NCI E-174-1993-1-US-01 METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN ... US CIP 08/379,420 6001555 Abandoned PDF
NCI E-052-1995-0-US-01 A METHOD FOR ISOLATING DENDRITIC CELLS US ORD 08/379,227 5643786 Abandoned PDF
NEI E-185-1992-2-US-02 DNA CLONES FOR THE EXPRESSION OF PIGMENT EPITHELIUM DERIVED FACTOR AND RELATED PROTEINS US CON 08/377,710 Abandoned
NCI E-157-1993-3-US-01 MIXTURES OF DIDEOXY-NUCLEOSIDES AND HYDROXYCARBAMIDE FOR INHIBITING RE TROVIRAL SPREAD US CIP 08/378,219 Abandoned
NHLBI E-188-1993-0-PCT-02 No_Patent_Title PCT PCT PCT/US95/00924 Abandoned
NIDCR E-034-1994-2-CA-03 PEPTOMERS WITH ENHANCED IMMUNOGENICITY CA National Stage 2181590 Abandoned
NIDCR E-034-1994-2-EP-04 PEPTOMERS WITH ENHANCED IMMUNOGENICITY EP National Stage 95908585.3 Abandoned
NIDCR E-034-1994-2-AU-02 PEPTOMERS WITH ENHANCED IMMUNOGENICITY AU National Stage 16844/95 Abandoned
NIDCR E-034-1994-1-US-01 PEPTOMERS WITH ENHANCED IMMUNOGENICITY US CIP 08/375,100 5750332 Abandoned PDF
NIDCR E-034-1994-2-PCT-01 PEPTOMERS WITH ENHANCED IMMUNOGENICITY PCT PCT COMB PCT/US1995/000760 Expired
NCI E-062-1995-0-US-01 IMMUNOTOXIN-MEDIATED CONDITIONAL DISRUPTION OF SPECIFIC NEURONS IN TRANSGENIC MICE US ORD 08/375,113 Abandoned
NCI E-013-1994-0-PCT-02 Protein Tyrosine Kinase A6 PCT PCT PCT/US95/00601 Abandoned
NINDS E-106-1995-0-US-01 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY US ORD 08/371,530 Abandoned
NCI E-094-1994-0-US-01 JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3)c US ORD 08/373,934 7070972 Expired PDF
NIEHS E-009-1994-0-US-01 Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same US ORD 08/372,183 6005086 Expired PDF
NCI E-217-1994-0-US-01 CONFORMATIONALLY CONSTRAINED DIACYLGLYCEROL ANALOGUES US ORD 08/372,602 5874464 Abandoned PDF
NCI E-023-1994-0-PCT-02 No_Patent_Title PCT PCT PCT/US95/000527 Abandoned
NCI E-137-1995-0-US-01 RECOMBINANT POXVIRUS-HTLV, COMPOSITIONS AND USES RELATED APPLICATIONS US CIP 08/372,664 Expired
NCI E-057-1994-1-US-01 P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US ORD 08/370,909 5843648 Expired PDF
NCI E-054-1995-0-US-01 SYSTEM AND METHOD FOR SIMULATING A TWO-MULTIDIMENSIONAL RADIATION INTENSITY DISTRIBUTION OF PHOTON OR ELECTRON BEAMS US ORD 08/368,589 5526395 Expired PDF
NCI E-179-1992-0-US-02 HTS-1 GENE, A HUMAN TUMOR SUPPRESSOR GENE US FWC 08/369,043 5491064 Expired PDF
NCI E-160-1992-0-US-03 SUBSTRATE FOR THE EPIDERMAL GROWTH FACTOR RECEPTOR KINASE, ANTIBODIES THERETO AND METHODS OF USE THEREOF (eps8) US DIV 08/368,079 5610018 Expired PDF
NEI E-185-1992-3-US-01 PIGMENT EPITHELIUM DERIVED FACTOR: CHARACTERIZATION GENOMIC ORGANIZATION AND SEQUENCE OF THE PEDF GENE US CIP 08/367,841 6319687 Expired PDF
NIAID E-055-1991-0-US-03 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA US FWC 08/365,997 5853739 Expired PDF
NIEHS E-003-1991-0-US-07 HUMAN LACTOFERRIN US FWC 08/366,006 Abandoned
NCI E-201-1994-1-US-02 DIMERIC ARYLISOQUINOLINE ALKALOID COMPOUNDS US CON 08/363,684 5578729 Abandoned PDF
NIDDK E-058-1992-1-US-01 SPECTROSCOPIC IMAGING DEVICE EMPLOYING IMAGING QUALITY SPECTRAL FILTERS US CIP 08/363,363 5528368 Expired PDF
NCI E-196-1990-0-US-22 METHOD FOR DIAGNOSING TUMORS USING MOUSE MONOCLONAL ANTIBODIES US FWC 08/363,203 5612032 Abandoned PDF
NCI E-004-1990-0-US-08 ANTI-VIRAL COMPOUNDS AND THEIR USES US FWC 08/362,760 Abandoned
NCI E-051-1994-2-NL-19 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 NL EP 95906686.1 Expired
NCI E-051-1994-2-MC-18 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 MC EP 95906686.1 Expired
NCI E-051-1994-2-IE-16 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 IE EP 95906686.1 Expired
NCI E-051-1994-2-IT-17 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 IT EP 95906686.1 Expired
NCI E-051-1994-2-EP-04 USE OF MONOCLONAL ANTIBODIES OR SOLUBLE OLIGOMERIC LIGANDS IN THE MANUFACTURE OF A MEDICAMENT FOR THE PREVENTION OR TREATMENT OF NEOPLASTIC DISORDERS EP National Stage 95906686.1 Expired
NCI E-051-1994-2-GB-15 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 GB EP 95906686.1 Expired
NCI E-051-1994-2-CH-11 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 CH EP 95906686.1 Expired
NCI E-051-1994-2-AT-09 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 AT EP 95906686.1 Expired
NCI E-051-1994-2-BE-10 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 BE EP 95906686.1 Expired
NCI E-051-1994-2-DK-21 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 DK EP 95906686.1 Expired